BioCentury
ARTICLE | Company News

Optimata, Novartis simulation deal

January 7, 2002 8:00 AM UTC

Optimata (Tel Aviv, Israel) will use its mathematical algorithms and software tools to study the action mechanism of an undisclosed compound from Novartis (NVS; SWX:NOVN). Optima's initial computer mo...